Health and Economic Impact of the United States Varicella Vaccination Program, 1996-2020
- PMID: 36265847
- PMCID: PMC10941259
- DOI: 10.1093/infdis/jiac271
Health and Economic Impact of the United States Varicella Vaccination Program, 1996-2020
Abstract
Background: The aim of this study was to evaluate the health and economic impact of the varicella vaccination program on varicella disease in the United States (US), 1996-2020.
Methods: Analysis was conducted using the Centers for Disease Control and Prevention or published annual population-based varicella incidence, and varicella-associated hospitalization, outpatient visit, and mortality rates in the US population aged 0-49 years during 1996-2020 (range, 199.5-214.2 million persons) compared to before vaccination (1990-1994). Disease costs were estimated using the societal perspective. Vaccination program costs included costs of vaccine, administration, postvaccination adverse events, and travel and work time lost to obtain vaccination. All costs were adjusted to 2020 US dollars using a 3% annual discount rate. The main outcome measures were the number of varicella-associated cases, hospitalizations, hospitalization days, and premature deaths prevented; life-years saved; and net societal savings from the US varicella vaccination program.
Results: Among US persons aged 0-49 years, during 1996-2020, it is estimated that more than 91 million varicella cases, 238 000 hospitalizations, 1.1 million hospitalization days, and almost 2000 deaths were prevented and 118 000 life-years were saved by the varicella vaccination program, at net societal savings of $23.4 billion.
Conclusions: Varicella vaccination has resulted in substantial disease prevention and societal savings for the US over 25 years of program implementation.
Keywords: VAR; benefit; cost; impact; varicella disease; varicella vaccine.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Similar articles
-
Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44. doi: 10.1001/archpedi.159.12.1136. Arch Pediatr Adolesc Med. 2005. PMID: 16330737
-
Cost effectiveness and budget impact of universal varicella vaccination in Russia.Hum Vaccin Immunother. 2022 Nov 30;18(5):2045152. doi: 10.1080/21645515.2022.2045152. Epub 2022 Mar 8. Hum Vaccin Immunother. 2022. PMID: 35258445 Free PMC article.
-
Cost-effectiveness of a routine varicella vaccination program for US children.JAMA. 1994 Feb 2;271(5):375-81. JAMA. 1994. PMID: 8283587
-
Varicella prevention in the United States: a review of successes and challenges.Pediatrics. 2008 Sep;122(3):e744-51. doi: 10.1542/peds.2008-0567. Pediatrics. 2008. PMID: 18762511 Review.
-
Cost containment analysis of childhood vaccination against varicella in Israel.J Infect. 2004 Feb;48(2):119-33. doi: 10.1016/s0163-4453(03)00079-3. J Infect. 2004. PMID: 14720487 Review.
Cited by
-
The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England.J Infect Dis. 2024 Jul 25;230(1):e65-e74. doi: 10.1093/infdis/jiad420. J Infect Dis. 2024. PMID: 39052702 Free PMC article.
-
Impact of pharmacist interventions on immunisation uptake: a systematic review and meta-analysis.J Pharm Policy Pract. 2023 Dec 7;17(1):2285955. doi: 10.1080/20523211.2023.2285955. eCollection 2024. J Pharm Policy Pract. 2023. PMID: 38205195 Free PMC article.
-
Epidemiological Characteristics of Varicella Outbreaks - China, 2006-2022.China CDC Wkly. 2023 Dec 29;5(52):1161-1166. doi: 10.46234/ccdcw2023.218. China CDC Wkly. 2023. PMID: 38164468 Free PMC article.
-
25 Years of Varicella Vaccination in the United States.J Infect Dis. 2022 Oct 21;226(Suppl 4):S375-S379. doi: 10.1093/infdis/jiac251. J Infect Dis. 2022. PMID: 36265845 Free PMC article. No abstract available.
References
-
- Marin M, Guris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1–40. - PubMed
-
- Marin M, Leung J, Anderson T, Lopez A. Monitoring varicella incidence and vaccine impact in the United States: surveillance challenges and changing epidemiology, 1995–2019. JID 2022. - PubMed
-
- Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005; 294:797–802. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical